“CVS/pharmacy has developed and implemented a new, state-of-the-art retail electronic prescription management and record-keeping system at a cost of several hundred million dollars that is designed to comply with DEA and other regulatory requirements,” CVS said.
“Going forward, we remain committed to complying with all federal and state laws governing the dispensing of prescriptions and related record-keeping requirements.”
U.S. Attorney Sanford Coats, in a statement, said complying with federal controlled substance laws is vital to tackling the problem of prescription drug abuse.
“To combat this problem, it is essential that those who dispense controlled substances comply with DEA's record-keeping requirements,” Coats said. “This ensures that dispensers of prescription drugs remain accountable for the controlled substances within their control and makes the illegal diversion of those drugs more difficult.”